| News
Switzerland Innovation Park Basel Area offre des ateliers et séminaires pour innover
11.06.2019
Venez innover avec nous ! Tel est le slogan pour les ateliers et séminaires qui seront organisés dans le Switzerland Innovation Park Basel Area du Jura pour les entreprises jurassiennes. Un programme alléchant qui traitera autant de sujets de diversification que de thématiques telles que l’intelligence artificielle ou le design thinking. A coup sûr, ce sont des sujets qui vous intéresseront.
Switzerland Innovation Park Jura Workshops
Le Switzerland Innovation Park Basel Area, antenne du Jura, se positionne comme un accélérateur de développement de projets pour les entreprises jurassiennes. Son ouverture est programmée pour cet automne et permettra aux PME, start-ups et institutions locales de s’y installer, de venir travailler et échanger dans des locaux de 1200 mètres carrés comprenant des bureaux privés et partagés, des espaces communs et des surfaces modulables.
Pour aider les entreprises jurassiennes à relever les défis liés à la transformation industrielle, un riche programme de séminaires et d’ateliers sera mis sur pieds à partir de septembre 2019. Retrouvez plus d’informations sur toutes les thématiques proposées dans le flyer.
En cas de questions, n’hésitez pas à prendre contact avec M. Sébastien Meunier, Directeur Industrial Transformation and Entrepreneurship au T+41 61 295 50 15 ou par email à sebastien.meunier@baselarea.swiss.
Nous nous réjouissons d’accueillir vos inscriptions!
Pour plus d’informations : www.switzerland-innovation.com/baselarea
Share this article
Sign up to receive our newsletter in your inbox.
You might also be interested in
docdok.health involved in coronavirus research project
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.
Read More
Celonic agrees cooperation to combat coronavirus
The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two companies are planning to develop a drug to treat coronavirus.
Read More
Idorsia receives payment of 45 million US dollars
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..
Read More
Humard robot disinfects using UV light
Humard has developed a robot that can disinfect spaces using UV light. For this, the system manufacturer from the canton of Jura has adapted a mobile industrial robot that is otherwise used in warehouse logistics.
Read More
Roche authorized to distribute coronavirus antibody tests
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.
Read More
Basel is the most popular Swiss location for headquarters
Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.
Read More
Healthtech sector growing rapidly in the Basel Area
The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.
Read More
Support program has roots in Basel
The online program Selfapy supports people suffering from mental health conditions during the coronavirus lockdown. BaselArea.swiss has provided startup help by way of its DayOne initiative.
Read More
University Hospital Basel treats coronavirus patients with plasma
The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.
Read More
Botnar Research Center advancing research into coronavirus
The Basel-based Botnar Research Center for Child Health is providing capital in the amount of 15 million Swiss francs to its four partner institutions. In this way, the University of Basel should be in a position to advance research into dealing with the coronavirus outbreak.
Read More
